SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Silva, A.
Right arrow Articles by Martins, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silva, A.
Right arrow Articles by Martins, B
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

brief-report

Protective role of the HLA–A*02 allele in Portuguese patients with multiple sclerosis

AM Silva

Departamento de Neurologia, Centro Hospitalar do Porto – Hospital de Santo António, Porto, Portugalanadmsilva{at}yahoo.com

A Bettencourt

UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal

C Pereira

UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal

E Santos

Departamento de Neurologia, Centro Hospitalar do Porto – Hospital de Santo António, Porto, Portugal

C Carvalho

Unidade de Investigação, Centro de Genética Médica Jacinto de Magalhães, Porto, Portugal

D Mendonça

Departamento do estudo de populações, Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal

PP Costa

UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal; Unidade de Investigação, Centro de Genética Médica Jacinto de Magalhães, Porto, Portugal

L Monteiro

Departamento de Neurologia, Centro Hospitalar do Porto – Hospital de Santo António, Porto, Portugal

B Martins

UMIB – Instituto de Ciências Biomédicas Abel Salazar (ICBAS-UP), Porto, Portugal; Unidade de Investigação, Centro de Genética Médica Jacinto de Magalhães, Porto, Portugal

Background

Multiple sclerosis (MS) is associated with human leukocyte antigen (HLA) HLA–DRB1*15. Recent evidence that CD8 T cells are implicated in MS suggests that HLA class I may also contribute. An association of HLA–A*02 and A*03 alleles has been described.

Objectives

We examined the influence of HLA–A*02 and HLA–A*03 in Portuguese patients with MS, independently of HLA–DRB1*15 using a logistic regression model.

Conclusions

DRB1*15 increased the risk of developing MS and HLA–A*02 decreased the risk. A*03 had no effect. To analyze if HLA–A*02 association was independent from DRB1*15, an interaction between these two alleles was introduced in the model; no significant interaction was found.

Key Words: genetic susceptibility • HLA class I • multiple sclerosis • Portugal

Multiple Sclerosis, Vol. 15, No. 6, 771-774 (2009)
DOI: 10.1177/1352458509104588


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement